×
Dermatology COVID-19 Registries: Updates and Future Directions.
https://doi.org/10.1016/j.det.2021.05.013
Dermatologic Clinics; Freeman EE, Chamberlin GC et. al.

Sep 25th, 2021 - During the COVID-19 pandemic, rapid, real-world evidence is essential for the development of knowledge and subsequent public health response. In dermatology, provider-facing and patient-facing registries focused on COVID-19 have been important sources of research and new information aimed at guiding optimal patient care. The 7 dermatology registries included in this update now include more than...

Coronavirus Disease 2019 and Dermatology Practice Changes.
https://doi.org/10.1016/j.det.2021.05.004
Dermatologic Clinics; Torres AE, Ozog DM et. al.

Sep 25th, 2021 - The impact of the COVID-19 pandemic on dermatology practice cannot be overstated. At its peak, the pandemic resulted in the temporary closure of ambulatory sites as resources were reallocated towards pandemic response efforts. Many outpatient clinics have since reopened and are beginning to experience a semblance of pre-pandemic routine, albeit with restrictions in place. We provide an overview...

The Impact of COVID-19 on Teledermatology: A Review.
https://doi.org/10.1016/j.det.2021.05.007
Dermatologic Clinics; Yeboah CB, Harvey N et. al.

Sep 25th, 2021 - The accelerated implementation and use of teledermatology during the coronavirus disease 2019 pandemic has met with successes and challenges. This review explores how telemedicine was used in dermatology before the pandemic, the regulatory adaptions made in response to the pandemic, and the effectiveness of the rapid implementation of teledermatology during the coronavirus disease 2019 pandemic...

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services.
https://doi.org/10.1016/j.det.2021.05.015
Dermatologic Clinics; Rashid S, Tsao H

Sep 25th, 2021 - The COVID-19 pandemic has presented a unique set of challenges to cancer care centers around the world. Diagnostic and treatment delays associated with lockdown periods may be expected to increase the total number of avoidable skin cancer deaths. During this unprecedented time, dermatologists have been pressed to balance early surgical interventions for skin cancer with the risk of viral transm...

The Impact of the COVID-19 Pandemic on Global Health Dermatology.
https://doi.org/10.1016/j.det.2021.05.005
Dermatologic Clinics; Hannah C, Williams V et. al.

Sep 25th, 2021 - In this article, we discuss the impact of the COVID-19 pandemic on various areas of global health dermatology, including patient care, neglected tropical diseases, education, and collaborations. Information was collected from literature review and informal interviews with more than 20 dermatologists from around the world. Many of the setbacks and hardships experienced by the global health commu...

COVID-19 and Dermatology: One Year in Review.
https://doi.org/10.1016/j.det.2021.06.001
Dermatologic Clinics; Freeman EE, McMahon DE

Sep 25th, 2021 - COVID-19 and Dermatology: One Year in Review.|2021|Freeman EE,McMahon DE,|

How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: P...
https://doi.org/10.1016/j.det.2021.05.014
Dermatologic Clinics; Sun Q, McMahon DE et. al.

Sep 25th, 2021 - Coronavirus disease 2019 (COVID-19) brought the world to its knees. As each nation grappled with launching an effective response while simultaneously minimizing repercussions on health care systems, economies, and societies, the medical and scientific landscape shifted forever. In particular, COVID-19 has challenged and transformed the field of dermatology and the way we practice. In this artic...

Atrial Arrhythmias and the Pandemic.
https://doi.org/10.1016/j.jacep.2021.03.011
JACC. Clinical Electrophysiology; Chinitz LA

Sep 25th, 2021 - Atrial Arrhythmias and the Pandemic.|2021|Chinitz LA,|

The changing epidemiology of acute kidney injury syndromes in the face of emerging resp...
https://doi.org/10.1016/j.kint.2021.07.001
Kidney International; Thakkar J, Golestaneh L

Sep 25th, 2021 - In this issue, Birkelo et al. performed a rigorous analysis of acute kidney injury (AKI) differences in patients hospitalized with coronavirus disease 2019 versus influenza. Coronavirus disease 2019 AKI was more severe, with worse outcomes, than influenza, despite adjustment for confounders. Their findings highlight the need for development of a new category of AKI syndrome, "viral pandemic-ass...

Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplanta...
https://doi.org/10.1016/j.transproceed.2021.08.034
Transplantation Proceedings; Meshram HS, Kute VB et. al.

Sep 25th, 2021 - Limited data exist on the incidence and outcome of early coronavirus disease 2019 (COVID-19) in kidney transplantation recipients (KTR). A retrospective multicenter research study was conducted across 12 centers in India. We explored the symptomatology, demographic, laboratory findings, and outcome of COVID-19 within 30 days of transplantation. The outcome was compared with the overall KTR and ...

FDA Issues Orders Clarifying Rules for Marketing Sunscreens
https://www.medpagetoday.com/dermatology/skincancer/94712

Sep 24th, 2021 - WASHINGTON -- The FDA on Friday issued two orders officials say are aimed at making sunscreens safer and clarifying requirements regarding active ingredients, although for now there won't be any noticeable effect on which sunscreen products consumers see on retail shelves. "Americans can reduce risks from sun exposure with continued use of sun protection measures, including broad-spectrum sunsc...

Another MS Drug Class Causes Concern for COVID Vaccine Protection
https://www.medpagetoday.com/neurology/multiplesclerosis/94711

Sep 24th, 2021 - Multiple sclerosis (MS) patients treated with cladribine (Mavenclad) or teriflunomide (Aubagio) had appropriate humoral response against SARS-CoV-2 a month after vaccination, but those treated with anti-CD20 therapies or sphingosine-1-phosphate receptor (S1P) modulators did not, a Swiss study showed. Of 120 MS patients at the Neurocenter of Southern Switzerland who received either the Moderna o...

Walensky: Pfizer Boosters for High-Risk Workers a 'Scientific Close Call'
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/94710

Sep 24th, 2021 - Recommending Pfizer vaccine (Comirnaty) booster doses for adults at high occupational risk of COVID-19 exposure based on individual risk was not a decision that CDC Director Rochelle Walensky, MD, came to lightly. In a press briefing on Friday, Walensky described her decision as a "scientific close call," and reiterated that she listened to not only the CDC's Advisory Committee on Immunization ...

How Many Deaths Will New Cigarette Warnings Prevent?
https://www.medpagetoday.com/primarycare/smoking/94694

Sep 24th, 2021 - Assuming they survive an ongoing legal challenge and are as effective as advocates hope, the new graphic warnings to appear on cigarette packages beginning next year could prevent millions of deaths from smoking over the following 8 decades, researchers estimated. Modeling by Rafael Meza, PhD, of the University of Michigan in Ann Arbor, and colleagues indicated that, depending on the degree to ...

CDC Overrules Advisors on Pfizer Booster for High-Risk Workers
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/94692

Sep 24th, 2021 - In a rare move, CDC overruled the recommendations of the agency's Advisory Committee on Immunization Practices (ACIP) regarding who should get a booster of Pfizer's COVID-19 vaccine (Comirnaty). In a statement released early Friday, the agency said those at high risk of occupational exposure, such as healthcare workers, may receive the Pfizer booster shot at least 6 months after the two-dose pr...

Warning on Tylenol in Pregnancy; Multi-Dose Vial Flaw; Angiographic Catheter Recall
https://www.medpagetoday.com/infectiousdisease/covid19/94691

Sep 24th, 2021 - Note that some links may require registration or subscription. A consensus statement from more than 100 scientists and clinicians warned about the possible fetal development dangers of prenatal exposure to acetaminophen. (Nature Reviews Endocrinology) Does new Florida Surgeon General Joseph Ladapo, MD, PhD, have ties to controversial America's Frontline Doctors? (Slate) In other Florida news, a...

Two COVID-19 Vaccine Scientists Win 2021 Lasker Award in Medicine
https://www.medscape.com/viewarticle/959721

Sep 24th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Katalin Kariko, PhD, a senior vice president at BioNTech, and Drew Weissman, MD, PhD, a professor in vaccine research at the University of Pennsylvania, Philadelphia, Pennsylvania, made a breakthrough discovery by modifying messenger RNA (mRNA), which provides instructions to cells to make prote...

FDA Issues Proposed Order for Over-the-Counter Sunscreens
https://www.medscape.com/viewarticle/959728

Sep 24th, 2021 - Federal efforts to improve the quality, safety, and efficacy of over-the-counter sunscreens took a step forward today with the release of two orders aimed at updating regulatory requirements for most sunscreen products in the United States. "We see it as a key public health priority and our regulatory obligation to make sure that marketed sunscreen products offer protection from the sun's effec...

A Daily Pill to Treat COVID Could Be Just Months Away, Scientists Say
https://www.medscape.com/viewarticle/959705

Sep 24th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room. When her husband, Joe, 4...

Extension Study Finds Dupilumab Effective for Up To 1 Year in Teens With AD
https://www.medscape.com/viewarticle/959696

Sep 24th, 2021 - Serious adverse events remained rare and skin remained largely clear in adolescents treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis (AD) for up to 52 weeks in a phase 3 open-label extension trial, researchers reported. At 1 year, 86% of 50 remaining patients with weights under 60 kg (132 lb) had achieved 75% improvement (EASI-75; Eczema Area and Severity Index), and 7...